Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review

Special Episode: A Discussion on the Emerging Concept of Fetal Fentanyl Syndrome

In this special episode, Drs. Carla Marienfeld, Marcela Smid, Tanner Wright, and Ljuba Mirsky, discuss the emerging concept of fetal fentanyl syndrome.   Prenatal Fentanyl Exposure Association With... : Journal of Addiction Medicine [https://www.ovid.com/jnls/journaladdictionmedicine/abstract/10.1097/adm.0000000000001679~prenatal-fentanyl-exposure-association-with-characteristic?redirectionsource=fulltextview] Authors Whitley W, Cockerham C, Mirsky E, O’Brien J, Parilla B, Hawk G.   Descriptive Exploration of Features Among Infants... : Journal of Addiction Medicine [https://www.ovid.com/jnls/journaladdictionmedicine/abstract/10.1097/adm.0000000000001650~descriptive-exploration-of-features-among-infants-with?redirectionsource=fulltextview]  Authors: Davidson A, Benninger KL, Henninger ML, et al.   Fetal Fentanyl Syndrome: An Opportunity to... : Journal of Addiction Medicine [https://www.ovid.com/jnls/journaladdictionmedicine/abstract/10.1097/adm.0000000000001676~fetal-fentanyl-syndrome-an-opportunity-to-quantify-the-risk?redirectionsource=fulltextview]  Authors Hernandez-Diaz S, Huybrechts KF.

Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review

In this episode of Beyond The Abstract, Dr. Kathleen Adams stops by to talk about her new article Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review featured in the May/June issue of the Journal of Addiction Medicine.   Article Link: Low-dose Buprenorphine Initiation in Pregnancy: A Systematic Review [https://journals.lww.com/journaladdictionmedicine/abstract/2026/05000/low_dose_buprenorphine_initiation_in_pregnancy__a.12.aspx]

Episode Rewind | Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem

In today's Episode Rewind, we're revisiting our interview with Dr. Emily Pasman. Dr. Pasman talks about her article Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem. She discusses the findings from her study as well as the potential limitations of using a solely abstinence-focused treatment and recovery model for addiction care. Emily Pasman is a licensed social worker and postdoctoral research fellow at the University of Michigan Center for the Study of Drugs, Alcohol, Smoking, and Health. Her research aims to improve health equity for people who use drugs by expanding harm reduction interventions; supporting affected family members; and addressing disparities in service access, uptake, and outcomes. Grounded in her practice background in peer-delivered services, she uses participatory methods to engage people with lived and living experience in all aspects of the research process. - Article Link: Nonabstinence Among US Adults in Recovery From an Alcohol or Other Drug Problem [https://journals.lww.com/journaladdictionmedicine/abstract/2025/05000/nonabstinence_among_us_adults_in_recovery_from_an.17.aspx]

Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial

In this episode of Beyond The Abstract, Dr. Manish Jha stops by to talk about his new article Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial featured in the March/April issue of the Journal of Addiction Medicine.   Article Link: Craving, Impulsivity, and Subsequent Methamphetamine Use With Naltrexone-Bupropion Versus Placebo: Findings From a Randomized Clinical Trial [https://journals.lww.com/journaladdictionmedicine/abstract/2026/03000/craving,_impulsivity,_and_subsequent.12.aspx]

Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA

In this episode of Beyond The Abstract, Dr. Phil Durney and Dr. Kory London stop by the show to discuss their latest article featured in the current March/April issue of the Journal of Addiction Medicine titled Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA.   They discuss what medetomidine is, how it functions, and how its emergence in the fentanyl supply is impacting the opioid crisis in the US, as well as clinical management of medetomidine exposure and withdrawal in hospital and outpatient settings.   Article Link: Severe Fentanyl Withdrawal Associated With Medetomidine Adulteration: A Multicenter Study From Philadelphia, PA [https://journals.lww.com/journaladdictionmedicine/abstract/2026/03000/severe_fentanyl_withdrawal_associated_with.14.aspx]